CIK 0001681087 · Non-accelerated filer<br>Smaller reporting company
Tectonic Therapeutic, Inc.
Sign in to watch- Ticker
- TECX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 810710585
- Phone
- (339) 666-3320
- Business address
- 490 ARSENAL WAY, SUITE 200, WATERTOWN, MA
- Former names
- AvroBio, Inc., AVROBIO, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,920
- in 2 filings, $14K under 10b5-1 plans
Net −$13,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 86 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-04 | Lochner Daniel Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +32,862 | 32,862 | ||
| 2025-02-04 | Ruddy Marcella K. Chief Medical Officer | Grant or award | +17,876 | 49,941 | ||
| 2025-02-04 | Ruddy Marcella K. Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +32,502 | 32,502 | ||
| 2025-02-04 | REICIN ALISE Chief Executive Officer | Grant or award | +36,047 | 214,344 | ||
| 2025-02-04 | REICIN ALISE Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +101,953 | 101,953 | ||
| 2025-01-28 | Schwabish Marc Chief Business Officer | Option exercise | +2,700 | $2.38 | $6K | 4,700 |
| 2025-01-28 | Schwabish Marc Chief Business Officer | Option exercise · Employee Stock Option (Right to Buy) | −2,700 | 86,514 | ||
| 2024-12-09 | Schwabish Marc Chief Business Officer | Option exercise | +2,000 | $2.38 | $5K | 2,000 |
| 2024-12-09 | Schwabish Marc Chief Business Officer | Option exercise · Employee Stock Option (Right to Buy) | −2,000 | 89,214 | ||
| 2024-12-04 | REICIN ALISE Chief Executive Officer | Grant or award | +11,717 | 178,297 | ||
| 2024-12-04 | REICIN ALISE Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +6,000 | 6,000 | ||
| 2024-12-03 | McNamara Peter Chief Scientific Officer | Option exercise | +3,500 | $2.38 | $8K | 14,188 |
| 2024-12-03 | McNamara Peter Chief Scientific Officer | Option exercise · Employee Stock Option (Right to Buy) | −3,500 | 34,459 | ||
| 2024-10-22 | SPRINGER TIMOTHY A Director | Purchase | +300,000 | $33.59 | $10.1M | 4,096,764 |
| 2024-09-26 | SPRINGER TIMOTHY A Director | Purchase | +24,531 | $28.16 | $691K | 3,771,295 |
| 2024-09-26 | SPRINGER TIMOTHY A Director | Purchase | +18,999 | $29.13 | $553K | 3,790,294 |
| 2024-09-26 | SPRINGER TIMOTHY A Director | Purchase | +4,070 | $30.10 | $123K | 3,794,364 |
| 2024-09-26 | SPRINGER TIMOTHY A Director | Purchase | +2,400 | $30.87 | $74K | 3,796,764 |
| 2024-09-24 | SPRINGER TIMOTHY A Director | Other disposition | −1,240,893 | 310,223 | ||
| 2024-09-24 | SPRINGER TIMOTHY A Director | Other acquisition | +1,054,759 | 3,746,764 |
Page 6 of 10 · 188 trades